Fund Holdings — Bain Capital Life Sciences Investors, LLC

Total Portfolio Value:
$961.18M
Total Bought:
$27.24M
Total Sold:
$14.62M
Net Transaction:
+$12.62M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Nuvalent Inc2,697,2672,697,2670$204.61M$275.93M28.71%+$71.32M
Newamsterdam Pharma Company
ORDINARY SHARES
10,473,91310,473,9130$201.20M$173.87M18.09%-$27.34M
Disc Medicine, Inc.(IRON)1,795,7351,795,7350$80.93M$88.24M9.18%+$7.31M
Dianthus Therapeutics, Inc.(DNTH)3,013,4233,013,4230$77.99M$82.51M8.58%+$4.52M
Savara Inc.(SVRA)14,565,45714,565,4570$58.70M$61.76M6.43%+$3.06M
Pharvaris N V
COM
3,303,3813,303,3810$62.10M$61.18M6.36%-$924.9K
Annexon, Inc.(ANNX)8,449,2088,449,748+540$41.40M$50.02M5.20%+$8.62M
Solid Biosciences Inc4,034,5824,034,5820$22.88M$28.12M2.93%+$5.24M
Tango Therapeutics, Inc.(TNGX)2,892,6632,712,008-180,655$24.82M$20.88M2.17%-$3.94M
Kyverna Therapeutics, Inc.(KYTX)3,368,3703,368,3700$25.26M$16.47M1.71%-$8.79M
Mersana Therapeutics Inc8,663,6738,663,6730$17.41M$16.37M1.70%-$1.04M
Cabaletta Bio, Inc.(CABA)1,649,9642,760,888+1,110,924$12.34M$13.03M1.36%+$689.7K
X4 Pharmaceuticals, Inc.(XFOR)16,915,78416,915,7840$9.81M$11.32M1.18%+$1.51M
Century Therapeutics, Inc.(IPSC)5,410,3615,410,3610$13.80M$9.25M0.96%-$4.54M
Atea Pharmaceuticals, Inc.(AVIR)2,485,6382,485,6380$8.23M$8.33M0.87%+$99.4K
Cidara Therapeutics Inc0703,080+703,080$0$7.56M0.79%+$7.56M
Rapid Micro Biosystems, Inc.CL A(RPID)8,434,5608,434,5600$5.57M$7.51M0.78%+$1.94M
C4 Therapeutics, Inc.(CCCC)1,111,9101,111,9100$5.14M$6.34M0.66%+$1.20M
Syros Pharmaceuticals Inc2,749,8082,750,151+343$14.19M$5.91M0.62%-$8.28M
Nautilus Biotechnology, Inc.(NAUT)2,000,0002,000,0000$4.68M$5.70M0.59%+$1.02M
Marinus Pharmaceuticals Inc2,267,6802,693,380+425,700$2.65M$4.74M0.49%+$2.09M
Xilio Therapeutics, Inc.(XLO)3,785,4504,566,817+781,367$3.59M$3.60M0.37%+$10.6K
Invivyd, Inc.(IVVD)1,799,5951,799,5950$1.98M$1.84M0.19%-$144.0K
Newamsterdam Pharma CompanyW EXP 99 99 999
*W EXP 99/99/999
100,000100,0000$872.0K$700.0K0.07%-$172.0K
Aclaris Therapeutics, Inc.(ACRS)1,000,0000-1,000,000$1.10M$0—-$1.10M
Arcutis Biotherapeutics, Inc.(ARQT)1,030,7030-1,030,703$9.59M$0—-$9.59M
Page 1 of 1
Bain Capital Life Sciences Investors, LLC — 13F Holdings — Q3 2024 | TickerTrail